EPMA Journal
Scope & Guideline
Fostering breakthroughs through open access and shared knowledge.
Introduction
Aims and Scopes
- Predictive, Preventive, and Personalized Medicine (3PM):
The journal emphasizes the 3PM paradigm, aiming to identify risk factors and implement tailored interventions for individuals to prevent disease onset and progression. - Multi-Omics Approaches:
A significant focus is placed on multi-omics strategies, integrating genomic, metabolomic, proteomic, and microbiomic data to uncover biomarkers for disease prediction and management. - Artificial Intelligence and Machine Learning:
The journal frequently publishes research on the application of AI and machine learning in healthcare, particularly for predictive analytics, diagnosis, and treatment personalization. - Chronic Disease Management:
There is a consistent emphasis on developing innovative methods for managing chronic diseases, exploring how lifestyle, genetic, and environmental factors contribute to disease risk and progression. - Integration of Social Determinants of Health:
Research also explores the impact of social determinants on health outcomes, aiming to address health disparities and improve health equity through personalized approaches. - Innovations in Healthcare Technology:
The journal highlights advancements in healthcare technologies, such as digital biomarkers and telemedicine, that facilitate personalized care and enhance patient engagement.
Trending and Emerging
- Gut Microbiota and Health:
Recent publications highlight the increasingly recognized role of gut microbiota in various health conditions, including mental health and chronic diseases, emphasizing its importance in personalized medicine. - Digital Health Innovations:
The rise of digital health technologies, including mobile health applications and telemedicine, is a growing theme, as the journal explores their potential to enhance 3PM and patient engagement. - AI-Driven Predictive Models:
There is a marked increase in research applying artificial intelligence to develop predictive models for disease risk assessment and management, showcasing advancements in computational methodologies. - Holistic Approaches to Health:
Emerging research emphasizes holistic health approaches that consider psychological, social, and environmental factors alongside biological aspects, reflecting a comprehensive view of health. - Integration of Health Data:
The trend towards integrating diverse health data sources, including electronic health records and real-time monitoring, is gaining traction, aiming to improve predictive analytics and personalized interventions. - Targeted Cancer Therapies:
The journal is increasingly focusing on targeted therapies in oncology, particularly those informed by multi-omic profiling and personalized treatment plans, reflecting advancements in cancer management.
Declining or Waning
- Traditional Epidemiological Studies:
There is a noticeable decrease in publications focused solely on traditional epidemiological methods, as the journal shifts towards more innovative, data-driven approaches that incorporate complex bioinformatics and multi-omics. - Generalized Treatments Without Personalization:
Research that proposes generalized treatment protocols without considering individual patient profiles is becoming less frequent, as the journal emphasizes the need for personalized strategies tailored to specific patient needs. - Basic Laboratory Studies:
The journal is moving away from purely basic laboratory studies that do not translate into clinical applications, favoring studies that demonstrate clear pathways to practical implementation in patient care. - Narrowly Focused Disease Studies:
There is a decline in studies that focus on narrowly defined diseases without considering broader implications for predictive and preventive strategies, as the journal promotes a more integrative approach.
Similar Journals
Translational Research
Empowering Change in Biochemistry and MedicineTranslational Research, published by Elsevier Science Inc, stands at the forefront of the rapidly evolving fields of biochemistry, medicine, physiology, and public health. With an impressive 2023 Q1 ranking in these categories, this journal has established itself as a critical platform for disseminating innovative research that bridges the gap between laboratory findings and clinical application. The journal, which has been converging knowledge since 2006, is committed to advancing scientific understanding and improving health outcomes by publishing high-quality articles that reflect rigorous peer review and impactful findings. With its impressive Scopus rankings, including a rank of #5 in Biochemistry and #7 in Physiology, it is an essential resource for researchers, practitioners, and students dedicated to the translation of scientific breakthroughs into real-world health solutions. Transitioning to an open-access model, the journal enhances accessibility and engagement, inviting a global audience to participate in the discourse shaping the future of healthcare and disease management.
Iranian Red Crescent Medical Journal
Empowering Medical Innovation and ResearchThe Iranian Red Crescent Medical Journal, published by ZAMENSALAMATI PUBL CO, is a vital resource in the field of general medicine, offering a platform for researchers, professionals, and students seeking to disseminate and access significant medical findings. With an impressive Scopus ranking of #159 out of 862 in the General Medicine category, this journal represents the 81st percentile, underscoring its impact and relevance within the medical community. While its Scopus coverage is listed as discontinued since 2019, the journal continues to serve as an essential reference for innovative medical research and practices in Iran and beyond. Situated in Khorasan, Mashhad, this open-access publication encourages the sharing of knowledge while fostering advancements in medical science. Researchers and students will find it an indispensable tool for staying informed about critical developments and emerging trends in medicine.
Communications Medicine
Fostering collaboration across medical disciplines for better patient care.Communications Medicine is a leading journal in the interdisciplinary field of medical communications, published by SpringerNature. Dedicated to advancing the scientific exchange of knowledge, this journal aims to facilitate the dissemination of innovative research, pivotal findings, and critical discussions that shape patient care and healthcare practices globally. With a commitment to open-access publishing, Communications Medicine ensures that cutting-edge health research is easily accessible to professionals, researchers, and students alike, fostering collaborative efforts across various medical disciplines. Although the current impact factor and specific metrics such as HIndex and Scopus ranks are not available, the journal's reputation and association with SpringerNature, renowned for its robust academic publishing, solidify its importance as a valuable resource in the ever-evolving landscape of medical communications. Researchers interested in engaging with the latest advancements and contributing to the dialogue surrounding health technologies and methodologies will find this journal an essential platform for their work.
JAMA Network Open
Empowering healthcare with groundbreaking insights.JAMA Network Open is a premier open-access journal published by the American Medical Association, dedicated to advancing the field of medicine through the dissemination of high-quality research. With an ISSN of 2574-3805, this journal has emerged as a vital platform since its launch in 2018, granting unrestricted access to groundbreaking studies and innovative findings in various areas of medicine. Currently boasting an impressive impact factor and ranking in the top 4% (Q1) of General Medicine, JAMA Network Open holds the 23rd position among 636 journals in the medicine category on Scopus, solidifying its status as an influential contributor to the medical community. Aiming to foster collaborative learning and evidence-based practice, the journal attracts submissions from researchers, healthcare professionals, and students alike. By providing a robust forum for research dissemination and engagement, JAMA Network Open plays a crucial role in shaping contemporary medical discourse and enhancing patient care globally.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
Connecting practitioners with the latest clinical insights.DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, published by GEORG THIEME VERLAG KG, is a prominent journal in the field of general medicine, with a storied history dating back to 1875. With an ISSN of 0012-0472 and an E-ISSN of 1439-4413, this journal serves as a vital resource for medical professionals and researchers seeking to stay informed on the latest developments and research in medicine. As of 2023, it holds a Q4 ranking in the category of Medicine (Miscellaneous) and is positioned within the 40th percentile among its peers in general medicine, highlighting its relevance within the academic community. While not an open-access journal, DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT offers readers access to a diverse range of articles that encompass clinical studies, systematic reviews, and opinion pieces geared towards enhancing medical practice and research. Located in Stuttgart, Germany, the journal continues to contribute to the advancement of medical knowledge and serves as an indispensable tool for scholars and practitioners alike.
Cell Reports Medicine
Pioneering the future of healthcare with cutting-edge insights.Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.
Cancer Management and Research
Illuminating the complexities of oncology for better health.Cancer Management and Research, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing the field of oncology. Since its inception in 2009, this journal has established itself as a vital resource for researchers, clinicians, and healthcare professionals focused on cancer treatment and management. With its robust impact factor and impressive Scopus ranking in the 77th percentile of oncology medicine, it provides a prominent platform for sharing high-quality research. The journal covers a wide range of topics within cancer management, including innovative therapeutic strategies, clinical trials, patient care, and health policy, ensuring a comprehensive approach to current challenges in the field. Operating from New Zealand, it invites contributions that can shape the future of oncology and improve patient outcomes globally, making it an essential addition to the libraries of those engaged in cancer research and practice.
INTERNAL MEDICINE JOURNAL
Fostering Collaboration in Internal MedicineINTERNAL MEDICINE JOURNAL, published by Wiley, stands as a prominent platform in the field of internal medicine, reflecting the latest advancements and research across a broad spectrum of topics within the discipline. With an ISSN of 1444-0903 and an E-ISSN of 1445-5994, this journal caters to a global audience, primarily situated in the United Kingdom. As a testament to its scholarly impact, the journal holds a Q2 ranking in the Internal Medicine category for 2023, indicating its influence within the field, and ranks #82 out of 167 in Scopus, placing it within the 51st percentile. Covering a convergence of years from 2001 to 2024, the INTERNAL MEDICINE JOURNAL aims to disseminate high-quality research that advances clinical practice, with diverse open access options available for broader readership and engagement. This publication is essential for researchers, healthcare professionals, and students seeking to deepen their understanding of internal medicine and contribute to its ongoing evolution.
Lancet Digital Health
Connecting Research and Practice in the Digital Health Sphere.Lancet Digital Health is an esteemed Open Access journal published by ELSEVIER, dedicated to advancing the interdisciplinary field of digital health. Since its inception in 2019, the journal has rapidly established itself as a leading platform for disseminating high-quality research focusing on the implications of digital technology in healthcare delivery, health informatics, and patient management. Renowned for its rigorous peer-review process and commitment to academic excellence, Lancet Digital Health currently holds prestigious Q1 rankings across multiple categories including Decision Sciences, Health Informatics, and Medicine (miscellaneous) as of 2023. With an impressive impact in its field—ranked #1 in Health Informatics and within the top percentile of related disciplines—this journal offers vital insights into the ongoing transformations within health systems globally. Researchers, healthcare professionals, and students alike will find a wealth of cutting-edge studies, practical applications, and discussions on the future of digital health, fostering an evidence-based dialogue that is essential in today's rapidly evolving medical landscape.
Biomedica
Exploring the frontiers of molecular biology and medicine.Biomedica is a distinguished journal published by the Instituto Nacional de Salud in Colombia, dedicated to advancing knowledge within the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 1981, this Open Access journal has embodied a commitment to disseminating high-quality research, ensuring free and universal access to its published works. With an impressive Scopus Ranking—273rd out of 636 in Medicine and 148th out of 221 in Biochemistry, Genetics and Molecular Biology—Biomedica holds a Q3 category in both disciplines as of 2023, reflecting its growing impact and relevance in the scientific community. The journal welcomes contributions that further our understanding and lead to advancements in healthcare and biological sciences, serving as a critical resource for researchers, professionals, and students alike. The journal operates within a continuous publication model from 2001 to 2024, enriching the academic landscape with contemporary findings and fostering collaboration within the biomedical field.